Cefpiramide Sodium

头孢匹胺钠

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameCefpiramide Sodium
Drug Alias NameCefpiran头孢吡四唑头孢比四唑cefpiramidumcefpiramida +[11] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics > Third-generation cephalosporins
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsBurnsSepsisPharyngitis +[5] 
Global Approved IndicationsSepsisBacterial Infections
Approved Indications in ChinaSepsis
Original Approved Country/TerritoryUnited States
Original Approved Date1989/01/31
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesLek Pharmaceutical And Chemical Company DdYuhan CorpHainan Huluwa Pharmaceutical Group Co Ltd
Inactive CompaniesWyeth-Ayerst
Active IndicationsBurnsSepsisPharyngitis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeJ01DD11
Related LinksWikipediaDrugBankKEGG